APO Research
Talk to an analyst

APO RESEARCH · REPORT

Factor XIII Concentrate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Factor XIII Concentrate Market Outlook and Growth Opportunities 2026

2 January 2026192 pages

Choose your research edition.

Industry ResearchFactor XIII Concentrate Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Factor XIII Concentrate Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Factor XIII Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Factor XIII Concentrate Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Factor XIII Concentrate Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Factor XIII Concentrate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Factor XIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Factor XIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Factor XIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Factor XIII Concentrate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Factor XIII Concentrate market include CSL Behring. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Factor XIII Concentrate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Factor XIII Concentrate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Factor XIII Concentrate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Factor XIII Concentrate market size, projected growth trends, production technologies, key applications, and end-use industries.

Factor XIII Concentrate Segment by Company

CSL Behring

Factor XIII Concentrate Segment by Type

1000IU

1600IU

Factor XIII Concentrate Segment by Application

Hospital

Clinic

Factor XIII Concentrate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Factor XIII Concentrate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Factor XIII Concentrate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Factor XIII Concentrate significant trends, drivers, influence factors in global and regions.

6. To analyze Factor XIII Concentrate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Factor XIII Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Factor XIII Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Factor XIII Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Factor XIII Concentrate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Factor XIII Concentrate industry.

Chapter 3: Detailed analysis of Factor XIII Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Factor XIII Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Factor XIII Concentrate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Factor XIII Concentrate Industry Trends Table 2. Factor XIII Concentrate Industry Drivers Table 3. Factor XIII Concentrate Industry Opportunities and Challenges Table 4. Factor XIII Concentrate Industry Restraints Table 5. Global Factor XIII Concentrate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Factor XIII Concentrate Revenue Share by Company (2021-2026) Table 7. Global Factor XIII Concentrate Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Factor XIII Concentrate Sales Volume Share by Company (2021-2026) Table 9. Global Factor XIII Concentrate Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Factor XIII Concentrate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Factor XIII Concentrate Key Company Manufacturing Base & Headquarters Table 12. Global Factor XIII Concentrate Company, Product Type & Application Table 13. Global Factor XIII Concentrate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Factor XIII Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1000IU Table 18. Significant Companies of 1600IU Table 19. Global Factor XIII Concentrate Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Factor XIII Concentrate Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Factor XIII Concentrate Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Factor XIII Concentrate Sales Volume Share by Type (2021-2026) Table 23. Global Factor XIII Concentrate Sales Volume Share by Type (2027-2032) Table 24. Global Factor XIII Concentrate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Factor XIII Concentrate Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Factor XIII Concentrate Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Factor XIII Concentrate Sales Value Share by Type (2021-2026) Table 28. Global Factor XIII Concentrate Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Factor XIII Concentrate Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Factor XIII Concentrate Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Factor XIII Concentrate Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Factor XIII Concentrate Sales Volume Share by Application (2021-2026) Table 35. Global Factor XIII Concentrate Sales Volume Share by Application (2027-2032) Table 36. Global Factor XIII Concentrate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Factor XIII Concentrate Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Factor XIII Concentrate Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Factor XIII Concentrate Sales Value Share by Application (2021-2026) Table 40. Global Factor XIII Concentrate Sales Value Share by Application (2027-2032) Table 41. Global Factor XIII Concentrate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Factor XIII Concentrate Sales by Region (2021-2026) & (K Units) Table 43. Global Factor XIII Concentrate Sales Market Share by Region (2021-2026) Table 44. Global Factor XIII Concentrate Sales by Region (2027-2032) & (K Units) Table 45. Global Factor XIII Concentrate Sales Market Share by Region (2027-2032) Table 46. Global Factor XIII Concentrate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Factor XIII Concentrate Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Factor XIII Concentrate Sales Value Share by Region (2021-2026) Table 49. Global Factor XIII Concentrate Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Factor XIII Concentrate Sales Value Share by Region (2027-2032) Table 51. Global Factor XIII Concentrate Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Factor XIII Concentrate Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Factor XIII Concentrate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Factor XIII Concentrate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Factor XIII Concentrate Sales by Country (2021-2026) & (K Units) Table 56. Global Factor XIII Concentrate Sales Market Share by Country (2021-2026) Table 57. Global Factor XIII Concentrate Sales by Country (2027-2032) & (K Units) Table 58. Global Factor XIII Concentrate Sales Market Share by Country (2027-2032) Table 59. Global Factor XIII Concentrate Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Factor XIII Concentrate Sales Value Market Share by Country (2021-2026) Table 61. Global Factor XIII Concentrate Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Factor XIII Concentrate Sales Value Market Share by Country (2027-2032) Table 63. CSL Behring Company Information Table 64. CSL Behring Business Overview Table 65. CSL Behring Factor XIII Concentrate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. CSL Behring Factor XIII Concentrate Product Portfolio Table 67. CSL Behring Recent Development Table 68. Key Raw Materials Table 69. Raw Materials Key Suppliers Table 70. Factor XIII Concentrate Distributors List Table 71. Factor XIII Concentrate Customers List Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Factor XIII Concentrate Product Image Figure 2. Global Factor XIII Concentrate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Factor XIII Concentrate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Factor XIII Concentrate Sales (2021-2032) & (K Units) Figure 5. Global Factor XIII Concentrate Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Factor XIII Concentrate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1000IU Image Figure 10. 1600IU Image Figure 11. Global Factor XIII Concentrate Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Factor XIII Concentrate Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Factor XIII Concentrate Sales Volume Share by Type (2021-2032) Figure 14. Global Factor XIII Concentrate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Factor XIII Concentrate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Factor XIII Concentrate Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Factor XIII Concentrate Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Factor XIII Concentrate Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Factor XIII Concentrate Sales Volume Share by Application (2021-2032) Figure 22. Global Factor XIII Concentrate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Factor XIII Concentrate Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Factor XIII Concentrate Sales Value Share by Application (2021-2032) Figure 25. Global Factor XIII Concentrate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Factor XIII Concentrate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Factor XIII Concentrate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Factor XIII Concentrate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Factor XIII Concentrate Sales Value (2021-2032) & (US$ Million) Figure 30. North America Factor XIII Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Factor XIII Concentrate Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Factor XIII Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Factor XIII Concentrate Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Factor XIII Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Factor XIII Concentrate Sales Value (2021-2032) & (US$ Million) Figure 36. South America Factor XIII Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Factor XIII Concentrate Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Factor XIII Concentrate Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Factor XIII Concentrate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Factor XIII Concentrate Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Factor XIII Concentrate Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 1000IU
  • 1600IU
Applications
  • Hospital
  • Clinic
Companies covered
  • CSL Behring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Factor XIII Concentrate Sales Value (2021-2032)
  4. 1.2.2 Global Factor XIII Concentrate Sales Volume (2021-2032)
  5. 1.2.3 Global Factor XIII Concentrate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Factor XIII Concentrate Market Dynamics
  1. 2.1 Factor XIII Concentrate Industry Trends
  2. 2.2 Factor XIII Concentrate Industry Drivers
  3. 2.3 Factor XIII Concentrate Industry Opportunities and Challenges
  4. 2.4 Factor XIII Concentrate Industry Restraints
3 Factor XIII Concentrate Market by Company
  1. 3.1 Global Factor XIII Concentrate Company Revenue Ranking in 2025
  2. 3.2 Global Factor XIII Concentrate Revenue by Company (2021-2026)
  3. 3.3 Global Factor XIII Concentrate Sales Volume by Company (2021-2026)
  4. 3.4 Global Factor XIII Concentrate Average Price by Company (2021-2026)
  5. 3.5 Global Factor XIII Concentrate Company Ranking (2024-2026)
  6. 3.6 Global Factor XIII Concentrate Company Manufacturing Base and Headquarters
  7. 3.7 Global Factor XIII Concentrate Company Product Type and Application
  8. 3.8 Global Factor XIII Concentrate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Factor XIII Concentrate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Factor XIII Concentrate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Factor XIII Concentrate Market by Type
  1. 4.1 Factor XIII Concentrate Type Introduction
  2. 4.1.1 1000IU
  3. 4.1.2 1600IU
  4. 4.2 Global Factor XIII Concentrate Sales Volume by Type
  5. 4.2.1 Global Factor XIII Concentrate Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Factor XIII Concentrate Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Factor XIII Concentrate Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Factor XIII Concentrate Sales Value by Type
  9. 4.3.1 Global Factor XIII Concentrate Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Factor XIII Concentrate Sales Value by Type (2021-2032)
  11. 4.3.3 Global Factor XIII Concentrate Sales Value Share by Type (2021-2032)
5 Factor XIII Concentrate Market by Application
  1. 5.1 Factor XIII Concentrate Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Factor XIII Concentrate Sales Volume by Application
  5. 5.2.1 Global Factor XIII Concentrate Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Factor XIII Concentrate Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Factor XIII Concentrate Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Factor XIII Concentrate Sales Value by Application
  9. 5.3.1 Global Factor XIII Concentrate Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Factor XIII Concentrate Sales Value by Application (2021-2032)
  11. 5.3.3 Global Factor XIII Concentrate Sales Value Share by Application (2021-2032)
6 Factor XIII Concentrate Regional Sales and Value Analysis
  1. 6.1 Global Factor XIII Concentrate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Factor XIII Concentrate Sales by Region (2021-2032)
  3. 6.2.1 Global Factor XIII Concentrate Sales by Region: 2021-2026
  4. 6.2.2 Global Factor XIII Concentrate Sales by Region (2027-2032)
  5. 6.3 Global Factor XIII Concentrate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Factor XIII Concentrate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Factor XIII Concentrate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Factor XIII Concentrate Sales Value by Region (2027-2032)
  9. 6.5 Global Factor XIII Concentrate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Factor XIII Concentrate Sales Value (2021-2032)
  12. 6.6.2 North America Factor XIII Concentrate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Factor XIII Concentrate Sales Value (2021-2032)
  15. 6.7.2 Europe Factor XIII Concentrate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Factor XIII Concentrate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Factor XIII Concentrate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Factor XIII Concentrate Sales Value (2021-2032)
  21. 6.9.2 South America Factor XIII Concentrate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Factor XIII Concentrate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Factor XIII Concentrate Sales Value Share by Country, 2025 VS 2032
7 Factor XIII Concentrate Country-level Sales and Value Analysis
  1. 7.1 Global Factor XIII Concentrate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Factor XIII Concentrate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Factor XIII Concentrate Sales by Country (2021-2032)
  4. 7.3.1 Global Factor XIII Concentrate Sales by Country (2021-2026)
  5. 7.3.2 Global Factor XIII Concentrate Sales by Country (2027-2032)
  6. 7.4 Global Factor XIII Concentrate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Factor XIII Concentrate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Factor XIII Concentrate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Factor XIII Concentrate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Factor XIII Concentrate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Factor XIII Concentrate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL Behring
  2. 8.1.1 CSL Behring Company Information
  3. 8.1.2 CSL Behring Business Overview
  4. 8.1.3 CSL Behring Factor XIII Concentrate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CSL Behring Factor XIII Concentrate Product Portfolio
  6. 8.1.5 CSL Behring Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Factor XIII Concentrate Value Chain Analysis
  2. 9.1.1 Factor XIII Concentrate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Factor XIII Concentrate Sales Mode & Process
  6. 9.2 Factor XIII Concentrate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Factor XIII Concentrate Distributors
  9. 9.2.3 Factor XIII Concentrate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst